compounded glp 1 lawsuit New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA is moving to restrict

Gastroenterology & Hepatology , 21 (3), 172

The effect of palmitic acid on inflammatory response in macrophages: an overview of molecular mechanisms

coli: Escherichia coli These analogues act as high-affinity GLP-1RAs, achieving sustained receptor activation and clinical outcomes by circumventing rapid enzymatic degradation

The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke

These temperature-sensitive injectable treatments for type 2 diabetes and weight management must be stored correctly, transported safely, and administered on schedule, even when crossing time zones